Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This is a combination of three dietary supplements:
* **Daidzein:** An isoflavone found in soy.
* **Genistein:** Another isoflavone found in soy.
* **Palmitoylethanolamide (PEA):** An endogenous fatty acid amide.
These ingredients are often marketed for their anti-inflammatory and potential pain-relieving properties. Their efficacy and safety are not as well-established as FDA-approved medications.
## Primary Indications
* There are no FDA-approved indications for this combination.
* It is typically marketed for conditions such as chronic pain (e.g., neuropathic pain, osteoarthritis), inflammation, and menopausal symptoms.
## Adult Dosing
* Dosing varies significantly by product and intended use.
* Typical daily doses found in over-the-counter products range from:
* Daidzein: 10 mg to 50 mg
* Genistein: 10 mg to 50 mg
* Palmitoylethanolamide: 300 mg to 1200 mg
* Some sources suggest splitting doses throughout the day.
* Specific maximal daily doses are not established by regulatory bodies.
## Pediatric Dosing
* There is **no established pediatric dosing** for this combination.
* Use in pediatric populations is generally not recommended due to lack of safety and efficacy data.
## Dose Adjustments
* Dose adjustments are not established.
* Patients should be advised to start with the lowest available dose and titrate as needed and tolerated, under the guidance of a healthcare professional.
## Contraindications
* Hypersensitivity to any of the components.
* Pregnancy and breastfeeding: Safety is not established.
* Patients with hormone-sensitive cancers (e.g., breast, uterine, ovarian) should exercise caution due to the phytoestrogenic nature of daidzein and genistein; consult an oncologist.
## Adverse Effects
* Gastrointestinal upset (nausea, diarrhea, abdominal pain).
* Headache.
* Allergic reactions are possible.
* Long-term effects are not well-studied.
## Key Drug Interactions
* **Hormone Therapies:** Potential additive effects or interactions with oral contraceptives, hormone replacement therapy, or anti-estrogen medications.
* **Anticoagulants/Antiplatelets:** Soy isoflavones may have mild anticoagulant effects; caution with warfarin, aspirin, clopidogrel, etc.
* **CYP450 Enzymes:** Some isoflavones may interact with CYP enzymes, although clinical significance is unclear.
## Monitoring
* Monitor for therapeutic response (e.g., pain reduction, symptom improvement).
* Monitor for adverse effects.
* Patients with underlying medical conditions, especially hormone-sensitive cancers or coagulation disorders, should be closely monitored.
## Clinical Pearls
* This combination consists of dietary supplements; they are not regulated as drugs by the FDA. Potency and purity can vary between manufacturers.
* The evidence supporting the efficacy of this specific combination for its marketed indications is limited and often based on small studies or individual component research.
* It is crucial for patients to inform their healthcare providers about their use of this supplement due to potential interactions and lack of established safety data.
***
***Disclaimer:** This information is intended for educational purposes for healthcare professionals and does not constitute medical advice. Always verify current prescribing information, drug interactions, and patient-specific factors before initiating or modifying any therapy. Consult the most recent official product labeling and relevant clinical guidelines.*
